Comparative Effectiveness of Intravenous Tenecteplase versus Alteplase in Posterior Circulation Ischemic Stroke: A Systematic Review and Meta-Analysis.
Brain and Behavior · 2026-10-01 · Meta-analysis
Abstract
BACKGROUND: Posterior circulation ischemic stroke (PCIS) is associated with substantial morbidity and mortality, and the optimal intravenous thrombolytic strategy in this subgroup remains unclear. METHODS: We searched databases for studies comparing intravenous tenecteplase with alteplase in adults with PCIS. The primary outcome was functional independence at 90 days (mRS 0-2). Secondary outcomes included other functional outcomes, reperfusion, hemorrhagic complications, and mortality. RESULTS: Five studies involving 997 patients were included. Regarding efficacy outcomes, tenecteplase was associated with a significantly greater likelihood of achieving an ambulatory functional outcome at 90 days (mRS 0-3) [RR 1.29, 95% CI 1.03-1.60; p = 0.02] and improved pre-EVT perfusion [RR 2.18, 95% CI 1.06-4.46; p = 0.03]. No significant differences were observed for excellent functional outcome (mRS 0-1) [RR 1.19, 95% CI 0.91-1.56; p = 0.20], functional independence (mRS 0-2) [RR 1.10, 95% CI 0.89-1.37; p = 0.39], or post-EVT perfusion [RR 1.12, 95% CI 0.89-1.40; p = 0.34]. Regarding safety outcomes, no significant differences were observed between tenecteplase and alteplase for symptomatic intracranial hemorrhage (sICH) [RR 0.89, 95% CI 0.36-2.22; p = 0.81], any intracranial hemorrhage [RR 1.02, 95% CI 0.59-1.78; p = 0.94], parenchymal hematoma [RR 0.76, 95% CI 0.24-2.38; p = 0.64], or 90-day mortality [RR 0.88, 95% CI 0.66-1.17; p = 0.39]. CONCLUSION: Tenecteplase may improve reperfusion and ambulatory recovery without increasing hemorrhagic complications or mortality compared with alteplase in PCIS, although larger PCIS-specific studies are needed.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antithrombotics & thrombolytics · Thrombolytics
Related articles
- Maternal and Fetal Safety Outcomes of Thrombolytics for Ischemic Stroke in Pregnancy: A Systematic Review and Aggregated Case Series. (Neurology, 2026)
- Efficacy and Safety of Bridging Intravenous Thrombolysis in the "Drip-and-Ship" Model for Anterior and Posterior Circulation Stroke: A Systematic Review and Meta-Analysis. (J Vasc Interv Radiol, 2026)
- Tenecteplase, alteplase, and endovascular thrombectomy in extended-window acute ischemic stroke with intracranial large-vessel occlusion: a Bayesian network meta-analysis. (J Neurol, 2026)
- Thrombolysis in the Delayed Treatment Window for Acute Ischemic Stroke: Updated Systematic Review and Meta-Analysis. (Stroke, 2026)
- Clinical outcomes after intravenous thrombolysis for acute ischemic stroke in low- and middle-income countries: a pooled analysis of 67,917 patients and systematic review. (Neurol Res, 2026)
- Bridging Thrombolysis Versus Direct Endovascular Thrombectomy in Acute Ischemic Stroke Patients With ASPECTS ≤5: A Meta-Analysis. (Brain Behav, 2026)